Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch Article

Optimization of a Chromogenic Limulus Amebocyte Lysate (LAL) Assay for Automated Endotoxin Detection

D. M. Bussey and K. Tsuji
PDA Journal of Pharmaceutical Science and Technology November 1984, 38 (6) 228-233;
D. M. Bussey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Tsuji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

The chromogenic LAL assay was optimized using a LAL reagent (Lot 261, Associates of Cape Cod, Woods Hole, MA) designed for the gel-clot assay, and a chromogenic substrate, SPECTROZYME™ (American Diagnostica, Greenwich, CT). The chromogenic assay procedure involves the incubation of the LAL reagent and endotoxin standard or sample, followed by the subsequent incubation with the chromogenic substrate. Acetic acid is added to stop the enzymatic reaction and the yellow color formed is read spectrophotometrically at 405 nm. The assay was optimal when the 50-test vial of LAL reagent was reconstituted with 10 ml of 50 mM tris-buffer, pH 7.5 for the incubation of the LAL-endotoxin solution, and the 2 mM chromogenic substrate was prepared in 25 mM tris-buffer, pH 9.0 for the subsequent incubation to release p-nitroaniline(pNA) at pH 8.2. The optimum temperature for the entire reaction was 37 °C. The linear range of the standard curve for endotoxin detection and the sensitivity of the assay were dependent on the length of the LAL-endotoxin incubation and subsequent incubation periods. The linear region of the assay with incubation of the LAL and endotoxin for 15 min, followed by 3 min of subsequent incubation with the chromogenic substrate, was 0.1–0.6 endotoxin units (EU)/ml (r = 0.99). When the LAL-endotoxin incubation and the subsequent incubation times were increased to 30 and 5 min, respectively, the chromogenic LAL detected subpicogram quantities of endotoxin (0.005 EU/ml). The stability of the LAL reagent and the effect of other variables (e.g., ionic strength, buffer type and freezing) on LAL reactivity are discussed. The chromogenic LAL assay developed has been automated using a Zymate robotic system.

  • Copyright © Parenteral Drug Association. All rights reserved.

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology
Vol. 38, Issue 6
November-December
  • Table of Contents
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimization of a Chromogenic Limulus Amebocyte Lysate (LAL) Assay for Automated Endotoxin Detection
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Optimization of a Chromogenic Limulus Amebocyte Lysate (LAL) Assay for Automated Endotoxin Detection
D. M. Bussey, K. Tsuji
PDA Journal of Pharmaceutical Science and Technology Nov 1984, 38 (6) 228-233;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimization of a Chromogenic Limulus Amebocyte Lysate (LAL) Assay for Automated Endotoxin Detection
D. M. Bussey, K. Tsuji
PDA Journal of Pharmaceutical Science and Technology Nov 1984, 38 (6) 228-233;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Monitoring of Mannitol Phase Behavior during Freeze-Drying Using Non-Invasive Raman Spectroscopy
  • Long-Term Stabilization of a New Freeze-Dried and Albumin-Free Formulation of Recombinant Human Interferon Alpha 2b
  • Pharmaceutical Development of an Intravenous Dosage Form of Diacetylmorphine Hydrochloride
Show more RESEARCH ARTICLE

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire